1.480USD-0.67%Mkt Cap: 3.91M USDP/E: —Last update: 2026-06-01
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap3.91M USD
Enterprise Value10.26M USD
Revenue (TTM)1.31M USD
Gross Profit223.78K USD
Net Income (TTM)-7.37M USD
Revenue/Share1.287 USD
Last Price1.480 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.42
PEG—
EV/EBITDA-1.31
EV/Revenue7.80
P/S3.01
P/B-0.83
EPS (TTM)-6.76
EPS (Forward)-3.58
52W Range
1.2901% of range14.68
52W High14.68 USD
52W Low1.290 USD
Profitability
Gross Margin22.26%
Oper. Margin-1292.45%
EBITDA Margin0.00%
Profit Margin-732.51%
ROE-212.67%
ROA-137.25%
Growth
Revenue Growth-36.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.85M USD
CapEx (TTM)218.08K USD
FCF Margin-409.76%
FCF Yield-137.83%
Net Debt-3.19M USD
Net Debt/EBITDA0.41
Balance Sheet
Debt/Equity0.04
Current Ratio3.34
Quick Ratio1.96
Book Value/Sh-1.7970 USD
Cash/Share1.255 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 20, 2026
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)3.700 USD
Target Range3.700 USD – 3.700 USD
# Analysts1
Ownership
Shares Out.2.66M
Float2.44M
Insiders0.88%
Institutions9.60%
Short Interest
Short Ratio1.0d
Short % Float5.37%
Short % Out.5.32%
Shares Short141.53K
Short (prev mo.)182.29K
Technical
SMA 501.660 (-10.8%)
SMA 2003.639 (-59.3%)
Beta2.70
S&P 52W Chg27.70%
Avg Vol (30d)59.95K
Avg Vol (10d)61.36K
Technical Indicators
RSI (14)44.6
MACD-0.0742
MACD Signal-0.0943
MACD Hist.+0.0201
BB Upper1.678 USD
BB Middle1.511 USD
BB Lower1.343 USD
BB Width22.18%
ATR (14)0.1198 USD
Vol Ratio (20d)0.18x